Page 11 - Flipbook
P. 11
Galsky et al, abstract 4503
- UC histology 30 patients
- cT2-4aN0M0 No cystectomy
- ECOG 0-1
- Cisplatin-eligible 31 patients Nivo x 4 months
Clinical CR Treatment based on pts choice
76 patients 64 patients
Gemcitabine + Restaging: Cystectomy
Maximal Cisplatine + - Cysto + biopsies
TURBT Nivolumab - Cytology 1 patient
(4 cycles) - MRI
33 patients
NO Clinical CR Cystectomy
Co-primary endpoints:
1) Clinical complete response rate (slides: “in pts undergoing cystectomy”)
2) 2-year metastasis-free survival (slides: “in pts pursuing surveillance”)
Radiation Oncology
